Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
We can see a decrease in the price for Bio-Techne Corp.. Compared to yesterday it has lost -€1.000 (-1.330%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Bio-Techne Corp..
With a target price of 75 € there is a slightly positive potential of 2.04% for Bio-Techne Corp. compared to the current price of 73.5 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Bio-Techne Corp. | -1.330% | -4.545% | 4.255% | -3.289% | 3.521% | - | - |
Neogen Corp. | 3.360% | 1.653% | 8.850% | -27.647% | -32.787% | -66.531% | -50.597% |
Bio-Rad Labs Inc. A | -1.520% | -1.624% | 0.077% | -25.058% | -11.274% | -45.502% | - |
Merit Medical Systems | -1.340% | -2.000% | 4.255% | -6.369% | 8.088% | 47.590% | 57.270% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat